Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia or CLL causes a slow increase in the number of white blood cells in the bone marrow. The cancerous cells spread from the bone marrow to the blood, and can also affect the lymph nodes and other organs. CLL eventually causes the bone marrow to fail and weakens the immune system.

Learn more about CLL, clinical trials and the latest treatments.

Living With CLL

Facing CLL Together: Session Two Replay

Watch the replay of the afternoon session of our “Facing CLL Together” Town Meeting to learn about tools for education and advocacy, supportive resources and strategies for managing life with CLL.

Al Hollis, Teresa Hollis, Carol Preston, Lee Swanson, Farrukh Awan, MD, Philip Thompson, MB, BS, Nicole Lamanna, MD

Ask the Expert

Your Questions, Expert Answers: CLL Treatment, Research and More

This “Ask the Expert” program features dedicated CLL researcher Dr. William Wierda on-site at the 2019 American Society of Hematology (ASH) annual meeting answering questions from CLL patients and care partners on treatment, testing, side effect management and more.

William Wierda, MD, PhD, Andrew Schorr

Latest News

Treatments

Understanding Personalized Care in CLL and Mantle Cell Lymphoma

Thomas Kipps, MD, PhD, Brad Kahl, MD, Ian W. Flinn, MD, PhD, Andrew Schorr, Esther Schorr

Treatments

61st ASH Annual Meeting & Exposition

Ask the Expert

CLL: Where We Have Been and Looking to the Future

Andrew Schorr, Michael Keating, MB, BS, William Wierda, MD, PhD

Living With CLL

What “I’m Fine” Really Means in CLL

Jeff Folloder, Dave Kasanicky, Lynnda Kasanicky

Ask the Expert

Expert Perspective: Does Every CLL Patient Need Every Test?

Farrukh Awan, MD, Nicole Lamanna, MD, Carol Preston

Living With CLL

Facing CLL With Faith and Hope

Jay Connolly, Jeff Folloder, Pat Weatherspoon-Hall, Elizabeth Dechen

Living With CLL

Managing Stress After a CLL Diagnosis

Andrew Schorr, Mark Silverstein, Paul Salmon, PhD, MS

Ask the Expert

How Can CLL Patients Benefit from IVIG?

Susan J. Leclair, PhD, CLS (NCA), Andrew Schorr, Justin Taylor, MD

Treatments

Sequencing Novel Agents for CLL

Edward A. Faber, Jr., DO, MS, Jeff Folloder

Treatments

First- and Second-Line CLL Treatment Approaches

Edward A. Faber, Jr., DO, MS, Jeff Folloder

Treatments

Newly Approved Drug for CLL: Acalabrutinib (Calquence)

Living With CLL

Talking to Friends About a Loved One’s CLL

Jay Connolly, Maureen Connolly, Andrew Schorr, Ruth Schorr

Find a clinical trial

Learn More